Related Experiment Video

Updated: Jun 5, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

G protein-coupled receptors: novel targets for drug discovery in cancer

Rosamaria Lappano1, Marcello Maggiolini

  • 1Department of Pharmaco-Biology, University of Calabria, 87030 Rende, Cosenza, Italy.

Nature Reviews. Drug Discovery
|January 4, 2011
PubMed

Insights

New research explores targeting G protein-coupled receptors (GPCRs) for cancer treatment. Manipulating GPCR pathways offers novel strategies for drug discovery in cancer prevention and therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • G protein-coupled receptors (GPCRs) are crucial cell surface proteins involved in numerous physiological processes.
  • Dysregulation of GPCRs is implicated in various diseases, notably cancer development and metastasis.
  • Existing GPCR-targeted drugs benefit many patients, but only a small fraction of GPCRs are targeted.

Purpose of the Study:

  • To review recent advancements in understanding GPCRs in cancer.
  • To identify novel GPCR targets for cancer prevention and treatment.
  • To explore new therapeutic strategies by manipulating GPCR-mediated pathways.

Main Methods:

  • Literature review of recent findings on GPCRs in cancer.
  • Analysis of current data on novel GPCR targets.
  • Discussion of therapeutic opportunities for GPCR manipulation.

Main Results:

  • GPCR-mediated pathways present unexpected opportunities for interfering with tumorigenic signals.
  • Several novel GPCRs are emerging as promising targets for cancer drug discovery.
  • Current drug development focuses on expanding the repertoire of targeted GPCRs.

Conclusions:

  • Targeting GPCRs holds significant promise for developing new cancer therapies.
  • Further research into novel GPCR targets can enhance cancer prevention and treatment strategies.
  • Manipulating GPCR pathways offers a viable approach to combat cancer progression.

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay11:49

Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay

Published on: July 28, 2014

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...